ALZHEIMER

Cuba maintains a priority to fight Alzheimer’s disease

Published on: September 21, 2022
12:15

By: Ileana Ferrer Fonte

Havana, Sep 21 (Prensa Latina) Cuba has as a priority to fight Alzheimer's disease and other dementias, while it researches drugs to improve the patients' quality of life, Granma newspaper reported on Wednesday.

Alzheimer’s: Epidemic requiring action and research

Published on: September 21, 2022
09:43

By: Pavel López Lazo

Havana, Sep 21 (Prensa Latina) Action Research is the scoop that accompanies today's World Alzheimer's Day, a mental illness considered the new epidemic of the 21st century.

Cuban research to treat Alzheimer’s disease highlighted in India

Published on: August 17, 2022
11:31

By: Alina Ramos Martin

New Delhi, Aug 17 (Prensa Latina) The development by Cuban scientists of the drug NeuralCIM, a neuroprotector for nasal use for Alzheimer's disease and other forms of dementia, is highlighted by the Indian portal Peoples Dispatch.

Cuba’s success in Alzheimer’s and Parkinson’s treatment

Published on: July 20, 2022
10:47

By: Alina Ramos Martin

Mexico City, Jul 20 (Prensa Latina) Cuba continues to be at the forefront in the development of medical treatments for the benefit of mankind, especially in diseases such as Alzheimer's and Parkinson's disease.

Mexican weekly praises Cuban method to treat Alzheimer’s, Parkinson’s

Published on: July 17, 2022
13:44

By: Pavel López Lazo

Mexico City, Jul 17 (Prensa Latina) The Mexican newspaper La Jornada on Sunday said that Cuba, pioneer nation in developing new technologies to treat neurodegenerative diseases, is presently applying a too successful treatment against Alzheimer's and Parkinson's.

Research on patients for drug trials to continue in Cuba

Published on: July 14, 2022
09:06

By: Aleynes Palacios Hurtado

Havana, Jul 14 (Prensa Latina) The classification consultations for patients with Alzheimer's disease who will soon be part of the phase III clinical trial of the Cuban neuroprotective drug NeuralCIM (NeuroEPO) will continue in this city on Thursday

Diaz-Canel praises Cuba’s breakthroughs against Alzheimer’s disease

Published on: July 8, 2022
00:46

By: Aleynes Palacios Hurtado

Havana, Jul 8 (Prensa Latina) Cuban President Miguel Diaz-Canel praised Cuba's scientific breakthroughs against Alzheimer's disease after the announcement of clinical trials that will be carried out with the drug NeuralCIM (NeuroEPO) soon.

Strategy for dementia and Alzheimer´s care presented in Cuba

Published on: April 6, 2022
09:37

By: Alina Ramos Martin

Havana, Apr 6 (Prensa Latina) Experts presented the Strategy for people with dementia and Alzheimer´s care in Cuba and insisted on the importance of passing knowlegde to caregivers, in a meeting with president Miguel Diaz-Canel.

Future processes of NeuroEpo against Alzheimer’s explained in Cuba

Published on: March 28, 2022
14:38

By: Juan M. Garcia

Havana, Mar 28 (Prensa Latina) NeuroEPO, Cuba's neuroprotective drug to counteract mild and moderate Alzheimer's disease, concluded phase II/III studies and a stage IV of progressive introduction of the product is being prepared, a scientific authority noted on Monday.

Cuban drug against Alzheimer’s disease gives hope to the world

Published on: March 23, 2022
00:15

By: Juan M. Garcia

Havana, Mar 23 (Prensa Latina) The neuroprotective drug NeuralCIM, which is administered nasally, gives patients with Alzheimer's disease in Cuba and other latitudes hope from science.

NEWS